Advertisement

Topics

Latest "Oxford Therapeutics Consulting Limited" News Stories

12:34 EDT 18th August 2018 | BioPortfolio

Here are the most relevant search results for "Oxford Therapeutics Consulting Limited" found in our extensive news archives from over 250 global news sources.

More Information about Oxford Therapeutics Consulting Limited on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Oxford Therapeutics Consulting Limited for you to read. Along with our medical data and news we also list Oxford Therapeutics Consulting Limited Clinical Trials, which are updated daily. BioPortfolio also has a large database of Oxford Therapeutics Consulting Limited Companies for you to search.

Showing "Oxford Therapeutics Consulting Limited" News Articles 1–25 of 9,500+

Relevant

Oxford University Press to publish Antibody Therapeutics

(Oxford University Press USA) Oxford University Press and the Chinese Antibody Society are pleased to announce their new partnership to launch the journal Antibody Therapeutics this spring.


Forma Therapeutics, University of Oxford partner to advance DUB inhibitors development

Forma Therapeutics and the University of Oxford have entered into a collaboration and license agreement to identify, validate and develop deubiquitinating enzyme (DUB) inhibitors for the treatment of neurodegenerative diseases.

Therapeutics and collaboration in the spotlight at Technology Showcase

This year’s Technology Showcase, held on 13 June at Oxford’s Saïd Business School, attracted a host of leading academics, clinicians and investors to discuss the most exciting commercial opportunities and projects in the field of Therapeutics, Small Molecules and Biologics. The event, which was attended by around 200 people, was organised by the NIHR Oxford BRC, ... Read more


Forma Therapeutics, University of Oxford to advance development of DUB inhibitors to treat neurodegenerative diseases

Forma Therapeutics and the University of Oxford have entered into a collaboration and license agreement to identify, validate and develop deubiquitinating enzyme (DUB) inhibitors for the treatment of neurodegenerative diseases.

Forma, U. Oxford collaborate on DUBs for neurodegenerative diseases

Forma Therapeutics Holdings LLC and several units of the University of Oxford are collaborating to identify, validate, and de...

Evox Therapeutics expands into new facilities at Oxford Science Park

The exosome therapeutics company announced the expansion will enhance its research and development capabilities and will facilitate its growth

Oxford University Press and Chinese Antibody Society partner to launch Antibody Therapeutics

Oxford University Press and the Chinese Antibody Society are pleased to announce their new partnership to launch the journal Antibody Therapeutics this spring.

Oxford Keeps Growing as a Hotspot for Cancer Vaccines with New Fundraising

Oxford Vacmedix has secured $12.5M (€10M) to start its first clinical trials, joining other Oxford-based biotechs in the cancer vaccine field such as Vaccitech and SpyBiotech. Oxford Vacmedix has secured Series A financing to continue the development of its two lead ... This awesome article Oxford Keeps Growing as a Hotspot for Cancer Vaccines with New Fundraising appeared first on Labiotech.eu...

Oxford BioMedica: Vector Value: An Interview with Nick Woolf, SVP Corporate Strategy

Fintan Walton talks to Nick Woolf, Senior Vice President, Corporate Strategy, Oxford BioMedica, about the company’s ongoing success as it moves toward its ultimate goal of becoming a fully integrated specialty pharmaceutical company. They review the company’s history and the finances that have been raised since its successful public listing on AIM in 1996. Together, they discuss the challenges...

Oxford woman sheds nearly six stone after diabetes diagnosis – Oxford Mail

Oxford MailOxford woman sheds nearly six stone after diabetes diagnosisOxford MailA DIABETES diagnosis was a wake-up call for one Oxford woman who has now shed nearly six stone. 0 comment. Retired nurse Rachel Griffin, 56, from Greater Leys said she was 'shell-shocked' at receiving the diagnosis last year after a routine blood test.and more

Parental controls do not stop teens from seeing pornography, new research finds

(University of Oxford) New research from the Oxford Internet Institute, University of Oxford has found that Internet filtering tools are ineffective and in most cases, were an insignificant factor in whether young people had seen explicit sexual content.

FORMA, University of Oxford collaborate to develop deubiquitinating enzyme inhibitors to treat neuro degenerative diseases

FORMA Therapeutics and the University of Oxford have entered into a collaboration and license agreement to identify, validate and develop deubiquitinating enzyme (DUB) inhibitors for the treatment of neuro

DNA Sequencing Unicorn Oxford Nanopore Raises £100M round at £1.5B valuation

Undeterred by competitors, Oxford Nanopore Technologies, one of the few unicorns in the biotech space, has secured £100M (€113M) to continue growing its unique next generation sequencing platform. Oxford Nanopore is one of the best-funded biotechs in Europe, having raised £507.3M (€578M) in total, and famous ... This awesome article DNA Sequencing Unicorn Oxford Nanopore Raises £100M ...

DNA Sequencing Unicorn Oxford Nanopore Raises £100M Round at £1.5Bn Valuation

Undeterred by competitors, Oxford Nanopore, one of the few unicorns in the biotech space, has secured £100M (€113M) to continue growing its unique next-generation sequencing platform. Oxford Nanopore is one of the best-funded biotechs in Europe, having raised £507.3M (€578M) in total, and famous for its “DNA-reading ... This awesome article DNA Sequencing Unicorn Oxford Nanopore...

Oxford Immunotec Announces Launch of the Accutix Brand

Oxford Immunotec Global (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced the launch of the Accutix brand for its tick-borne disease offering. As quoted in the press release: “Incorporating the feedback of our customers was a key consideration in our selection of a new brand name,” said Dr. Peter Wrighton-Smith, Chief Executive Officer of Oxford … Continued The po...

Oxford Impact 2018 workshop

Last month, the NIHR Oxford BRC and the UK Cochrane Collaboration organised the Oxford Impact 2018 workshop, which brought together people from a wide range of fields to “think differently about research impact”. The event sought to tackle one of the central challenges of what has become known as the ‘impact agenda’ in healthcare research: ... Read more

Isis Innovation: How the Oxford Sciences Innovation fund is promoting investment in the Oxfordshire region

Adam Stoten, head of Technology Transfer at Isis Innovation (the technology transfer arm of the University of Oxford) discusses the recent successes of Oxford Sciences Innovation (OSI), a fund comprising six key investors: Invesco Asset Management Limited, IP Group plc, Lansdowne Partners (UK) LLP, Oxford University Endowment Fund, the Wellcome Trust, and Woodford Investment Management LLP.

Oxford researcher gets £1m boost to study immunology of asthma

A University of Oxford researcher has received a £1m grant to expand his research into the immunology of lung diseases, including asthma. Dr Tim Hinks has been awarded a Wellcome Trust Clinical Research Career Development Fellowship. The funding that comes with the award will allow Dr Hinks, who is also supported by the NIHR Oxford ... Read more

Oxford Firm Develops Better Test for ALS Diagnosis

Oxford BioDynamics has presented data from a new diagnostic test that could help not just diagnose ALS but also help patients get a personalized treatment. Amyotrophic lateral sclerosis (ALS) is a motor neuron disease whose diagnosis comes with the hard ... This awesome article Oxford Firm Develops Better Test for ALS Diagnosis appeared first on Labiotech.eu. Be kind and don't copy it without aski...

Health minister visits Oxford BRC

The Health Minister, Lord O’Shaughnessy, visited the NIHR Oxford BRC on Wednesday 30 May to take a look at the ground-breaking research that is taking place in the fields of cancer and genomics. He was accompanied on the tour by Oxford BRC Director Prof Keith Channon and Head of Research Operations Dr Vasiliki Kiparoglou. Lord O’Shaughnessy ... Read more

Evox Therapeutics expands into new facilities at The Oxford Science Park

Expansion significantly increases laboratory space, creating new job opportunities in the area

Ultrasound and nanomedicine offer new hope for improving effects of cancer drugs

In a breakthrough that allows the more precise targeting of drugs at cancers, a University of Oxford team has used ultrasound and lipid drug carriers to remotely trigger and enhance the delivery of a cancer drug in humans for the first time. The study was conducted by researchers from the University of Oxford and Oxford University ... Read more

Oxford Centre for Haematology stages inaugural event

The new Oxford Centre for Haematology has held its inaugural event at Keble College, Oxford. The event, which will be held annually, was attended by around 200 academics, healthcare professionals and representatives of industry. Some speakers travelled from as far away as the United States. The event was opened by Prof Paresh Vyas, Director of ... Read more

Oxford Nanopore Completes $140 Million Funding Led by Asian Investors

Oxford Nanopore Technologies, a UK company that offers several portable real-time DNA/RNA sequencers, completed a $140 million funding led by Asian investors. The investors were GIC (the Singapore sovereign wealth fund), China Construction Bank and Hostplus of Australia. Existing investors also participated. Oxford Nanopore will apply the funds to its continuing commercial expansion, including a m...

Cerenis Therapeutics: Jean-Louis Dasseux

In this episode of PharmaTelevision News Review, Paul Burge talks with Jean-Louis Dasseux, CEO and President at Cerenis Therapeutics. Filmed at the PharmaTelevision studios in Oxford, UK.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks